A contingent including representatives from 12 area life-sciences companies and the major institutions on the Buffalo Niagara Medical Campus is in Chicago this week for the BIO International Convention.
The delegation is attending the convention for the first time under the “Buffalo Niagara BIO” brand after taking part for the past five or six years as a member of the larger “New York Loves BIO” group.
The convention, which began Monday and runs through Thursday, is the largest international event for the biotech industry and typically draws 20,000 people and company representatives, offering important networking and business opportunities, according to Buffalo Niagara Enterprise, one of this year’s participants.
In addition to the BNE, local convention attendees include representatives of the New York State Center of Excellence in Bioinformatics and Life Sciences, the Hauptman-Woodward Medical Research Institute and companies such as Empire Genomics, QuaDPharma and Immco Diagnostics.
But Western New York is tossing its hat in the ring - lightly. The giant STAMP (Science Technology and Advanced Manufacturing Park) planned for Genesee County would be perfect for such a plant, but it might not be ready in time for Apple's move. The Town of Alabama just voted to rezone the 1,200-acre site, and now funding is being sought for buying land and building infrastructure.
If Apple goes elsewhere, planners are gearing up to be ready for the next big one.
Cleveland BioLabs, an emerging life sciences company, is working on anti-radiation sickness drugs that can be used to help soldiers and cancer patients. Its department of chemistry and biological development plays a key role in this research.
Protectan, a drug designed for patients in the advanced stages of cancer, has started an advanced clinical trial. The drug was developed by Buffalo biotechnology company Cleveland BioLabs. The drug is meant to treat radiation sickness, but the company says it has also been successful treating cancerous tumors in animals.
It's part of an effort toward increased transparency. Past and projected financial information, assumptions and other data submitted by insurers when requesting rate hikes can now be found on the state Department of Financial Services Web site.
Despite the state's unique abilities and potential in the field, the state still struggles to compete against other states and is losing out on opportunities to create jobs. To remedy that, the report says the state should push for more investment in life sciences firms.
Fannie Mae's newest retained attorney list notes the local firm is "not eligible for new referrals."
A bankrupt Jamestown furniture maker has filed notice with the state that it will close its manufacturing plant in February. The filing comes just two months after Crawford Furniture said it would close its retail stores to focus on manufacturing. Company representatives said it hopes the plant's closing will be temporary while the company ramps up its network of independent retailers to sell through nationally. But if its attempts at securing more national retail channels fails, the plant will close for good and 101 workers will lose their jobs.
Profits are up at Greatbatch. The medical and electrochem company had a 17 percent increase in profits during the third quarter. The spike was attributed to higher sales across its medical products businesses and lower interest costs.
But the company takes the stations one step further than just plugging into the electrical grid--the stations are powered by wind and solar energy. Employees with electric cars can charge their cars for free during the workday.